Literature DB >> 1095612

Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

J E Balow, D L Hurley, A S Fauci.   

Abstract

The characteristics of cyclophosphamide-induced suppression of established ccll mediated immunity were studied in guinea pigs previously senstized to tuberculin. Cyclophosphamide treatment for 5 days produced a dose-dependent peripheral lymphoctopenia and disproportionatley greater neutrophenia which was particularly striking at high doses of 20 mg/kg per day(approximaetly 200 mg/kg-2 per day). Lymphoctes remianing in the circulation of cyclophosphamide treeated aniamls showed a doses-dependent reduction to both in vitro proliferactive and macrophage migration inhibitory factor responses to tuberculin compared to lymphocte responses of controls. Proliferative responses to phytohemaggultinin and concanavalin a were not significatly suppressed. Additional studies showed that cyclophosphamide suppressed the porliferactive and migration inhibitroy factor responses to tuberculin of lymph node and splenic as well as cirulating lymphocte populations. These studies showed that relatively short-term cyclophospamide administration produced immunosuppresion by quantitative as well as qualitative changes in lymphocyte populations. Significant suppresion of lymphocte function, howerver, was achived only with doses of cyclophoshamide which also produced a severe neutropenia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095612      PMCID: PMC436556          DOI: 10.1172/JCI108080

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Selective depletion of Ig-bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and systemic lupus erythematosus. Guidelines for dosage.

Authors:  D A Horwitz
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

2.  Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis.

Authors:  A S Fauci; D C Dale; S M Wolff
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

Review 3.  Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.

Authors:  J R David; R R David
Journal:  Prog Allergy       Date:  1972

4.  Immune response of patients with rheumatoid arthritis during cyclophosphamide treatment.

Authors:  J E Curtis; J T Sharp; M D Lidsky; E M Hersh
Journal:  Arthritis Rheum       Date:  1973 Jan-Feb

5.  T cell rosette formation in primates, pigs, and guinea pigs. The influence of immunosuppresive agents.

Authors:  K S Johansen; T S Johansen; D W Talmage
Journal:  J Allergy Clin Immunol       Date:  1974-08       Impact factor: 10.793

6.  Immunologic unresponsiveness to allergic thyroiditis in guinea pigs.

Authors:  S B Salvin; H L Liauw
Journal:  J Immunol       Date:  1967-03       Impact factor: 5.422

7.  Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis.

Authors:  P J Clements; D T Yu; J Levy; H E Paulus; E V Barnett
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

8.  Graft-versus-host disease in rats after donor treatment with cyclophosphamide and spleen cells of host origin.

Authors:  M P Fink; C L Cloud
Journal:  Transplantation       Date:  1974-05       Impact factor: 4.939

Review 9.  Cyclophosphamide: use in practice.

Authors:  M E Gershwin; E J Goetzl; A D Steinberg
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

10.  Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats.

Authors:  P Y Paterson
Journal:  J Immunol       Date:  1971-06       Impact factor: 5.422

View more
  12 in total

1.  Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.

Authors:  Stefano Di Biase; Changhan Lee; Sebastian Brandhorst; Brianna Manes; Roberta Buono; Chia-Wei Cheng; Mafalda Cacciottolo; Alejandro Martin-Montalvo; Rafael de Cabo; Min Wei; Todd E Morgan; Valter D Longo
Journal:  Cancer Cell       Date:  2016-07-11       Impact factor: 31.743

Review 2.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

3.  Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses.

Authors:  J E Balow; J E Parrillo; A S Fauci
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

4.  Polychlorinated biphenyl-induced modification of lymphocyte response to plant mitogens in rats.

Authors:  M Bonnyns; C H Bastomsky
Journal:  Experientia       Date:  1976-04-15

5.  Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs.

Authors:  A Winkelstein
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Quantitative and qualitative effects of cyclophosphamide administration on circulating polymorphonuclear leucocytes.

Authors:  G W Hunninghake; A S Fauci
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

7.  Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.

Authors:  Christina A To; Robert W Hsieh; James Scott McClellan; Walter Howard; Nancy J Fischbein; Janice M Y Brown; Dean W Felsher; Alice C Fan
Journal:  BMJ Case Rep       Date:  2012-09-07

8.  Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.

Authors:  H C Stevenson; A S Fauci
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

9.  Cyclophosphamide effects on murine cryptococcosis.

Authors:  J R Graybill; L Mitchell
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Amphotericin B and 5-fluorocytosine: in vitro effects on lymphocyte function.

Authors:  G A Roselle; C A Kauffman
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.